Worth an Arm and a Leg: The Critical Importance of Limb Ischemia.
作者信息
Valle Javier A, Waldo Stephen W
机构信息
1 Division of Cardiology Department of Medicine University of Colorado Aurora CO.
2 Division of Cardiology Department of Medicine Veterans Affairs Eastern Colorado Health Care System Denver CO.
出版信息
J Am Heart Assoc. 2018 Aug 21;7(16):e010093. doi: 10.1161/JAHA.118.010093.
Abstract
摘要
相似文献
1
Worth an Arm and a Leg: The Critical Importance of Limb Ischemia.极其昂贵：肢体缺血的至关重要性
J Am Heart Assoc. 2018 Aug 21;7(16):e010093. doi: 10.1161/JAHA.118.010093.
2
Autologous bone marrow cell transplantation increases leg perfusion and reduces amputations in patients with advanced critical limb ischemia due to peripheral artery disease.自体骨髓细胞移植可增加晚期严重肢体缺血（由外周动脉疾病所致）患者的下肢灌注并减少截肢。
Cell Transplant. 2009;18(3):371-80. doi: 10.3727/096368909788534942. Epub 2009 Apr 2.
3
Outcome after leg bypass surgery for critical limb ischemia is poor in patients with diabetes: a population-based cohort study.糖尿病患者下肢严重缺血行搭桥手术后的结局较差：一项基于人群的队列研究。
Diabetes Care. 2008 May;31(5):887-92. doi: 10.2337/dc07-2424. Epub 2008 Feb 11.
4
Quality improvement guidelines for percutaneous management of acute limb ischemia.急性肢体缺血经皮治疗的质量改进指南。
J Vasc Interv Radiol. 2005 May;16(5):585-95. doi: 10.1097/01.RVI.0000156191.83408.B4.
5
[A periarteritisnodosa presenting as bilateral sub-acute limb ischemia of the legs].[以双侧下肢亚急性缺血表现的结节性多动脉炎]
Ann Cardiol Angeiol (Paris). 2021 Oct;70(4):253-255. doi: 10.1016/j.ancard.2021.07.005. Epub 2021 Sep 10.
6
Femoral artery percutaneous revascularization for patients with critical limb ischemia: outcomes compared to patients with claudication over 2.5 years.股动脉经皮血运重建治疗肢体严重缺血患者：与 2.5 年以上跛行患者的结局比较。
Vasc Med. 2012 Jun;17(3):138-44. doi: 10.1177/1358863X12440141. Epub 2012 Apr 11.
7
Postoperative outcomes for patients undergoing elective revascularization for critical limb ischemia and intermittent claudication: a subanalysis of the Coronary Artery Revascularization Prophylaxis (CARP) trial.因严重肢体缺血和间歇性跛行接受择期血运重建的患者的术后结局：冠状动脉血运重建预防（CARP）试验的亚组分析
J Vasc Surg. 2006 Jun;43(6):1175-82. doi: 10.1016/j.jvs.2005.12.069.
8
Know how to respond if you have PAD and experience a "leg attack". Understand the symptoms that require immediate medical attention if you have peripheral arterial disease. Critical limb ischemia could lead to amputation.如果你患有外周动脉疾病（PAD）并经历“腿部发作”，要知道如何应对。了解如果你患有外周动脉疾病，哪些症状需要立即就医。严重肢体缺血可能导致截肢。
Heart Advis. 2011 Jan;14(1):1, 11.
9
One-year prospective quality-of-life outcomes in patients treated with angioplasty for symptomatic peripheral arterial disease.接受血管成形术治疗的有症状外周动脉疾病患者的一年期前瞻性生活质量结果。
J Vasc Surg. 2006 Aug;44(2):296-302; discussion 302-3. doi: 10.1016/j.jvs.2006.04.045. Epub 2006 Jul 11.
10
[Acute ischemia of the limbs].[肢体急性缺血]
Rev Prat. 2002 Apr 15;52(8):917-23.
引用本文的文献
1
The Midterm Outcomes of Endovascular Therapy for Femoropopliteal Lesions via Drug-Coated Balloon, Directional Atherectomy and Bare Metal Stent Angioplasty.经药物涂层球囊、定向斑块旋切术和裸金属支架血管成形术治疗股腘动脉病变的血管内治疗中期结果
Rev Cardiovasc Med. 2024 Sep 18;25(9):331. doi: 10.31083/j.rcm2509331. eCollection 2024 Sep.
2
Enhanced pericyte-endothelial interactions through NO-boosted extracellular vesicles drive revascularization in a mouse model of ischemic injury.通过增强型 NO 外泌体促进血管周细胞-内皮细胞相互作用，促进缺血性损伤小鼠模型中的血管新生。
Nat Commun. 2023 Nov 13;14(1):7334. doi: 10.1038/s41467-023-43153-x.
3
Successful Revascularization of Infrapopliteal Chronic Total Occlusions Using the Plantar Arch as a Conduit and Retrograde Pedal Access.以足底弓为导管并采用逆行足背入路成功实现腘下慢性完全闭塞病变的血管再通
Ochsner J. 2021 Summer;21(2):209-213. doi: 10.31486/toj.20.0085.
本文引用的文献
1
Determinants of Long-Term Outcomes and Costs in the Management of Critical Limb Ischemia: A Population-Based Cohort Study.关键肢体缺血管理的长期结局和成本的决定因素：一项基于人群的队列研究。
J Am Heart Assoc. 2018 Aug 21;7(16):e009724. doi: 10.1161/JAHA.118.009724.
2
Design and Rationale of the Best Endovascular Versus Best Surgical Therapy for Patients With Critical Limb Ischemia (BEST-CLI) Trial.严重肢体缺血患者最佳血管内治疗与最佳手术治疗对比试验（BEST-CLI）的设计与原理
J Am Heart Assoc. 2016 Jul 8;5(7):e003219. doi: 10.1161/JAHA.116.003219.
3
Contemporary cardiovascular risk and secondary preventive drug treatment patterns in peripheral artery disease patients undergoing revascularization.接受血运重建的外周动脉疾病患者的当代心血管风险及二级预防药物治疗模式
J Vasc Surg. 2016 Oct;64(4):1009-1017.e3. doi: 10.1016/j.jvs.2016.03.429. Epub 2016 May 18.
4
Epidemiology of peripheral arterial disease and critical limb ischemia in an insured national population.参保全国人口中周围动脉疾病和严重肢体缺血的流行病学
J Vasc Surg. 2014 Sep;60(3):686-95.e2. doi: 10.1016/j.jvs.2014.03.290. Epub 2014 May 10.
5
Adherence to guideline-recommended therapy is associated with decreased major adverse cardiovascular events and major adverse limb events among patients with peripheral arterial disease.在外周动脉疾病患者中，坚持遵循指南推荐的治疗与主要不良心血管事件和主要不良肢体事件的减少相关。
J Am Heart Assoc. 2014 Apr 10;3(2):e000697. doi: 10.1161/JAHA.113.000697.
6
Antithrombotic therapy in peripheral artery disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.外周动脉疾病的抗血栓治疗：抗血栓治疗与血栓预防，第 9 版：美国胸科医师学会循证临床实践指南。
Chest. 2012 Feb;141(2 Suppl):e669S-e690S. doi: 10.1378/chest.11-2307.
7
Variation in the use of lower extremity vascular procedures for critical limb ischemia.严重肢体缺血患者下肢血管手术使用情况的差异。
Circ Cardiovasc Qual Outcomes. 2012 Jan;5(1):94-102. doi: 10.1161/CIRCOUTCOMES.111.962233. Epub 2011 Dec 6.
8
ACCF/AHA/ACR/SCAI/SIR/SVM/SVN/SVS 2010 performance measures for adults with peripheral artery disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on performance measures, the American College of Radiology, the Society for Cardiac Angiography and Interventions, the Society for Interventional Radiology, the Society for Vascular Medicine, the Society for Vascular Nursing, and the Society for Vascular Surgery (Writing Committee to Develop Clinical Performance Measures for Peripheral Artery Disease).ACCF/AHA/ACR/SCAI/SIR/SVM/SVN/SVS 2010年外周动脉疾病成人患者的性能指标：美国心脏病学会基金会/美国心脏协会性能指标特别工作组、美国放射学会、心脏血管造影和介入学会、介入放射学会、血管医学学会、血管护理学会及血管外科学会（外周动脉疾病临床性能指标制定写作委员会）报告
Circulation. 2010 Dec 14;122(24):2583-618. doi: 10.1161/CIR.0b013e3182031a3c. Epub 2010 Nov 29.
9
Patients with peripheral arterial disease in the CHARISMA trial.CHARISMA试验中的外周动脉疾病患者。
Eur Heart J. 2009 Jan;30(2):192-201. doi: 10.1093/eurheartj/ehn534. Epub 2009 Jan 9.
10
Cost per day of patency: understanding the impact of patency and reintervention in a sustainable model of healthcare.每日通畅成本：在可持续医疗模式中理解通畅及再次干预的影响
J Vasc Surg. 2008 Dec;48(6):1489-96. doi: 10.1016/j.jvs.2008.07.003. Epub 2008 Oct 1.
Zotero 插件